Okasa Pharma Private Limited, a active private limited company, was established on 25 May 1990 in Mumbai-400 001.(Wef-27/8/2001), Maharashtra, India. Engaging in metal retail & distribution within the trade sector, it holds CIN: U24239MH1990PTC071153. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.50 Cr and a paid-up capital of ₹2.20 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Raman Parameswaran Athipotta (Director), Srinivas Hariharan (Director). Past directors included Vilas Gopal Khire, Raman Parameswaran Athipotta. It holds no open charges and ₹5.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12 Gunbow Street,,Fort,Mumbai, Mumbai-400 001.(Wef-27/8/2001), Maharashtra, 400001.
U24239MH1990PTC071153
071153
25 May 1990
₹10.50 Cr
₹2.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Okasa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raman Parameswaran Athipotta | Director | 31 Jan 2015 | Current |
| Srinivas Hariharan | Director | 04 Sep 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 31 Jan 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Okasa Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 83.99% decrease. The company also saw a substantial improvement in profitability, with a 93.57% increase in profit. The company's net worth dipped by a decrease of 0.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Okasa Pharma had a public holding of 13.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹52,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2004 | Axis Bank Limited | ₹3.75 Cr | Satisfied |
| 04 Jan 1993 | The Saraswat Co Operative Bank Ltd | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Okasa Pharma has a workforce of 1 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Okasa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okasa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Okasa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Okasa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 16 Nov 2004 via Charge ID 80002720 with Axis Bank Limited was fully satisfied on 16 May 2015. was completed.
The activity Raman Parameswaran Athipotta was appointed as a Director was appointed as a Director on 31 Jan 2015 & has been associated with this company since 10 years 10 months . was completed.
The activity A charge with Axis Bank Limited of Rs. 3.75 Cr registered on 16 Nov 2004 with Charge ID 80002720 was modified on 31 Mar 2006. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 3.75 Cr with Charge ID 80002720 was registered on 16 Nov 2004. was documented.
The CIN of Okasa Pharma Private Limited is U24239MH1990PTC071153.
Okasa Pharma Private Limited is headquartered at 12 Gunbow Street,,Fort,Mumbai, Mumbai-400 001.(Wef-27/8/2001), Maharashtra, 400001.
Okasa Pharma Private Limited was incorporated on 25 May 1990.
The current directors of Okasa Pharma Private Limited are
The primary industry of Okasa Pharma Private Limited is Trade.
Okasa Pharma Private Limited is unlisted.
The authorized capital of Okasa Pharma Private Limited is ₹10.50 Cr, and the paid-up capital is ₹2.20 M.
The compliance status of Okasa Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX